By: Christoph Emmerich

Presentation of the newly developed Guidelines On Target Validation for Innovative Therapeutics (GOT-IT)
November 22, 2019

Representing the GOT-IT Team, Christoph Emmerich presented the GOT-IT Guidelines at the “BMBF Vernetzungstreffen zur Nationalen Wirkstoffinitiative” on the 8th of October…

Read More
License to Kill – From Killer Experiments and Synthetic Lethality
August 12, 2019

The Maternal Embryonic Leucine zipper Kinase (MELK) is an interesting enzyme:In 2005, MELK was first implicated in cancer by finding elevated…

Read More